Research and validation cohorts
prostate
PROSTATE
From June 2018 to January 2020, we retrospectively and consecutively analyzed 967 patients who underwent prostate bpMRI and RP. Exclusion criteria: (1) Patients who did not receive standardized MRI scans or underwent MRI scans at other centers; (2) Patients on neoadjuvant therapies; (3) Patients with transurethral resection of the prostate; (4) Patients who received hormone or radiotherapy after RP before BF; and (5) Patients with insufficient clinical data and undetermined PSA results from postoperative follow-up. Finally, 446 patients met our inclusion criteria (Fig. Calibration plot showing mean predicted risk in the validation cohort. (